Healthcare Reimbursement

CMMI End-Stage Renal Disease Treatment Choices Model

Published July 26, 2019 3:29 pm | Updated April 20, 2026 3:32 pm

On July 10, 2019, the Center for Medicare & Medicaid Innovation (CMMI) proposed the End-Stage Renal Disease (ERSD) Treatment Choices (ETC) Model, a six-and-a-half-year mandatory payment model focused on beneficiaries with ESRD. The model is designed to increase the use of in-home dialysis (as opposed to in-facility, which is the predominant model) and kidney transplantation rates by adjusting payments to clinicians and ESRD facilities based on their patients’ rates of home dialysis and transplantation. The model will run from January 1, 2020 through June 30, 2026.

Advertisements

googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text7' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );

{{ loadingHeading }}

{{ loadingSubHeading }}

We’re having trouble logging you in.

For assistance, contact our Member Services Team.

Your session has expired.

Please reload the page and try again.